PartsTable
Technical Data Sheet
Download PDF

NDC00013-5616-93 — CYCLOPHOSPHAMIDE FOR INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00013-5616-93: CYCLOPHOSPHAMIDE FOR INJECTION.

The CYCLOPHOSPHAMIDE FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, special_features: VIAL W/NOT LESS THAN 15 ML OF VOLUME; NOTE: D, features_provided: STERILE, primary_container_type: VIAL, therapeutic_equivalent: NEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC., protective_storage_feature: ANTINEOPLASTIC DRUG. This part is cataloged in the U.S.

Government catalog under NSN 6505-00-767-3578, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00013-5616-93
NSN: 6505-00-767-3578
FSC: 6505 — Drugs and Biologicals
CAGE: 58750 — ERBAMONT INC ADRIA LABORATORIES DIV (USA)
SPECIFICATIONS
physical_formPOWDER
special_featuresVIAL W/NOT LESS THAN 15 ML OF VOLUME; NOTE: D
features_providedSTERILE
primary_container_typeVIAL
therapeutic_equivalentNEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC.
protective_storage_featureANTINEOPLASTIC DRUG
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
warning_and_caution_statementsCHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
total_primary_container_quantity12
primary_container_content_quantity200.000 MILLIGRAMS OF ACTIVE INGREDIENT
active_medicament_medicinal_strength200.000 MILLIGRAMS CYCLOPHOSPHAMIDE, ANHYDROUS ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyCYCLOPHOSPHAMIDE FOR INJECTION USP 200MG VIAL 12S PG
NSN6505-00-767-3578
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available CYCLOPHOSPHAMIDE FOR INJECTION TITLE COMPONENT PN NDC00013-5616-93 MFR CYCLOPHOSPHAMIDE FOR I
KEY FEATURES
•
THERAPEUTIC EQUIVALENT: NEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC.
•
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLIGRAMS OF ACTIVE INGREDIENT
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
FEATURES PROVIDED: STERILE
•
PRIMARY CONTAINER TYPE: VIAL
•
PHYSICAL FORM: POWDER
•
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
TECHNICAL CHARACTERISTICS
THERAPEUTIC EQUIVALENTNEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC.
PRIMARY CONTAINER CONTENT QUANTITY200.000 MILLIGRAMS OF ACTIVE INGREDIENT
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
FEATURES PROVIDEDSTERILE
PRIMARY CONTAINER TYPEVIAL
PHYSICAL FORMPOWDER
SPECIAL FEATURESVIAL W/NOT LESS THAN 15 ML OF VOLUME; NOTE: D
PROTECTIVE STORAGE FEATUREANTINEOPLASTIC DRUG
PART NAME ASSIGNED BY CONTROLLING AGENCYCYCLOPHOSPHAMIDE FOR INJECTION USP 200MG VIAL 12S PG
WARNING AND CAUTION STATEMENTSCHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
SUBSTITUTES & CROSS-REFERENCES 2
NDC00087-0501-01Same NSN cross-reference
Same NSN cross-reference
Also cataloged under this NSN
NEOSARReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
HAZMAT per U.S. Government catalogShelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required
Ready to buy NDC00013-5616-93?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00013-5616-93?
NDC00013-5616-93 is a CYCLOPHOSPHAMIDE FOR INJECTION.
What parts can replace NDC00013-5616-93?
There are 2 known substitutes for NDC00013-5616-93: NDC00087-0501-01, NEOSAR. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00013-5616-93?
NDC00013-5616-93 is cataloged in the U.S. Government catalog under NSN 6505-00-767-3578. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00013-5616-93